Capital Markets Capital Markets

AMF not successful in convincing Court of Appeal in a market manipulation case

The Québec Court of Appeal recently rendered a judgment addressing the elements constituting an offence for market manipulation as set forth in...

Government of Ontario rejects CSA proposal on embedded commissions

Earlier today, the Canadian Securities Administrators published proposed regulatory amendments that would prohibit the payment of commissions to...

Good news to report about Canadian trade reports – Private placement trade reporting becomes easier in October

In June 2016, the Canadian Securities Administrators (CSA) introduced new rules for reporting sales of securities in Canada under private placement...

Ontario Court of Appeal clarifies jurisdictional limits of secondary market claims in Yip v. HSBC Holdings plc

The recent judgment of the Ontario Court of Appeal in Yip v. HSBC Holdings plc provides helpful guidance on the jurisdictional limits of secondary...

Cannabis Act passes final vote in Senate

On June 19, 2018, the Senate voted to pass Bill C-45, the Cannabis Act. Senators voted 52-29, with two abstentions, to pass the final version of the...

Cannabis Act passes in Senate with amendments

After six months of study, Bill C-45, the Cannabis Act, passed third reading in the Senate. The Senate voted to adopt the Bill with a total of 46...

CSA concludes real estate issuers should improve disclosure relating to distributions and non-GAAP financial measures

The Canadian Securities Administrators (CSA) have concluded that the quality and completeness of disclosure by real estate reporting issuers relating...

New guidance for referring to a TSX listing application in a prospectus or other document

The TSX has issued new guidance explaining when and how issuers can refer to an application to list securities on the TSX in a prospectus or other...

Poison pills under the new bid regime: lessons & questions flowing from Canada’s largest cannabis M&A deal to date

On March 15, 2018, the OSC and the Financial Consumer Affairs Authority of Saskatchewan issued their reasons for the Aurora-CanniMed decision.